TS
Thaduri Srivani
About Thaduri Srivani
Data last updated:
Thaduri Srivani is a Director at Stereokem Private Limited (since 2013), Director at Stereokem Pharmaceuticals Private Limited (since 2012) and Director at Genotech Pharmaceuticals Private Limited (since 2021), and holds 1 more current directorship. The companies operate in Pharma. The 4 current companies with reported revenue have a combined latest revenue of ₹20.49 Cr; the largest is Stereokem Private Limited at ₹13.93 Cr (FY 2024). Earlier, Thaduri Srivani was a Director at Stereokem India Private Limited (from 2013).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Feb 2013 | 2009 | ₹13.93 Cr (FY 2024) | Active | |
| Director | 26 Dec 2012 | 2012 | ₹6.31 Cr (FY 2023) | Active | |
| Director | 25 May 2021 | 2010 | ₹25.4 Lakh (FY 2025) | Active | |
| Director | 28 May 2009 | 2008 | ₹15,000 (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 23 May 2013 | 2013 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Thaduri Srivani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Venkateshwar Thaduri Kumar | 02381317 | Stereokem Private Limited , Stereokem Pharmaceuticals Private Limited and 1 more | Director |
| Venugopala Bandi Rao | 07290550 | Stereokem Private Limited | Director |
| Narayana Varma Vegiraju | 09554153 | Stereokem Pharmaceuticals Private Limited | Director |
| Murari Rajakumari | 09198855 | Genotech Pharmaceuticals Private Limited | Director |
| Ravi Kumar Pericherla | 07513020 | Genotech Pharmaceuticals Private Limited | Director |
| Suryanarayana Kolagani | 07518632 | Genotech Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Thaduri Srivani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Thaduri Srivani
Thaduri Srivani currently holds 4 directorships: Stereokem Private Limited (Director, since 16 Feb 2013, revenue ₹13.93 Cr (FY 2024)); Stereokem Pharmaceuticals Private Limited (Director, since 26 Dec 2012, revenue ₹6.31 Cr (FY 2023)); Genotech Pharmaceuticals Private Limited (Director, since 25 May 2021, revenue ₹25.4 Lakh (FY 2025)); Jyostna Laboratories Private Limited (Director, since 28 May 2009, revenue ₹15,000 (FY 2024)).
Thaduri Srivani was first appointed on 28 May 2009 as Director at Jyostna Laboratories Private Limited. The most recent appointment on record is 25 May 2021 at Genotech Pharmaceuticals Private Limited.
The 4 current companies of Thaduri Srivani that report revenue have a combined latest revenue of ₹20.49 Cr: Stereokem Private Limited ₹13.93 Cr (FY 2024); Stereokem Pharmaceuticals Private Limited ₹6.31 Cr (FY 2023); Genotech Pharmaceuticals Private Limited ₹25.4 Lakh (FY 2025); Jyostna Laboratories Private Limited ₹15,000 (FY 2024).
Thaduri Srivani held 1 earlier board appointment: Stereokem India Private Limited (Director, from 23 May 2013).
The current boards of Thaduri Srivani's companies include Venkateshwar Thaduri Kumar (Stereokem Private Limited), Venugopala Bandi Rao (Stereokem Private Limited), Narayana Varma Vegiraju (Stereokem Pharmaceuticals Private Limited), Murari Rajakumari (Genotech Pharmaceuticals Private Limited), Ravi Kumar Pericherla (Genotech Pharmaceuticals Private Limited), Suryanarayana Kolagani (Genotech Pharmaceuticals Private Limited).